The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2018
Filed:
Sep. 21, 2015
Applicant:
National Health Research Institutes, Miaoli County, TW;
Inventors:
Kak-Shan Shia, Taipei, TW;
Jiing-Jyh Jan, Miaoli County, TW;
Lun Kelvin Tsou, Miaoli County, TW;
Chiung-Tong Chen, Miaoli County, TW;
Yu-Sheng Chao, New York, NY (US);
Assignee:
National Health Research Institutes, Miaoli County, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); A61K 31/517 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07F 9/6558 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 473/32 (2006.01); C07D 239/95 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/517 (2013.01); C07D 239/95 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 473/32 (2013.01); C07F 9/65583 (2013.01);
Abstract
Heterocyclic compounds of Formula (I) shown herein. Also disclosed are pharmaceutical compositions containing the heterocyclic compounds and methods of using the heterocyclic compounds to mobilize hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation. Further provided are methods for treating tissue injury, cancer, inflammatory disease, and autoimmune disease with the heterocyclic compounds.